These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23322822)

  • 21. [The significance of Ki-67 antigen expression in the distinction between benign and malignant pheochromocytomas].
    Feng C; Li HZ; Yan WG; Gao JG; Xu WF; Luo YF; Cao JL
    Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1697-700. PubMed ID: 18476530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The usefulness of phosphorylated-signal transduction and activators of transcription 3 in detecting prostate cancer from negative biopsies.
    Han G; Yu JY; Chen YD; Cao XL; Zhu J; Wang W; Wang XX; Zhang X; Yan JQ; Gao JP
    Eur J Surg Oncol; 2012 Apr; 38(4):367-73. PubMed ID: 22261084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive activation of signal transducers and activators of transcription 3 correlates with better prognosis, cell proliferation and hypoxia-inducible factor-1α in human gastric cancer.
    Woo S; Lee BL; Yoon J; Cho SJ; Baik TK; Chang MS; Lee HE; Park JW; Kim YH; Kim WH
    Pathobiology; 2011; 78(6):295-301. PubMed ID: 22104200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stathmin as a marker for malignancy in pheochromocytomas.
    Björklund P; Cupisti K; Fryknäs M; Isaksson A; Willenberg HS; Akerström G; Hellman P; Westin G
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):27-30. PubMed ID: 19449284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase-2 expression correlates with phaeochromocytoma malignancy: evidence for a Bcl-2-dependent mechanism.
    Cadden IS; Atkinson AB; Johnston BT; Pogue K; Connolly R; McCance D; Ardill JE; Russell CF; McGinty A
    Histopathology; 2007 Dec; 51(6):743-51. PubMed ID: 17916073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Histology, immunocytochemistry and DNA cytophotometry of adrenal glandpheochromocytoma (PCC)--a morphologic clinal study of 64 tumors].
    Padberg BC; Achilles E; Garbe E; Dralle H; Klöppel G; Schröder S
    Verh Dtsch Ges Pathol; 1990; 74():289-94. PubMed ID: 1708605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas.
    Gao B; Meng F; Bian W; Chen J; Zhao H; Ma G; Shi B; Zhang J; Liu Y; Xu Z
    Urology; 2006 Aug; 68(2):282-6. PubMed ID: 16904437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma.
    Lee SE; Oh E; Lee B; Kim YJ; Oh DY; Jung K; Choi JS; Kim J; Kim SJ; Yang JW; An J; Oh YL; Choi YL
    Oncotarget; 2016 Apr; 7(17):24141-53. PubMed ID: 27007161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
    Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S
    Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66.
    Guillemot J; Thouënnon E; Guérin M; Vallet-Erdtmann V; Ravni A; Montéro-Hadjadje M; Lefebvre H; Klein M; Muresan M; Seidah NG; Anouar Y; Yon L
    J Mol Endocrinol; 2012 Apr; 48(2):115-27. PubMed ID: 22217803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical evaluation of heat shock protein expression in normal canine nerve and peripheral nerve sheath tumours.
    Romanucci M; Berardi I; Ciccarelli A; Bongiovanni L; Malatesta D; Oevermann A; Della Salda L
    J Comp Pathol; 2013; 149(2-3):216-20. PubMed ID: 23348018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions.
    Elstrand MB; Stavnes HT; Tropé CG; Davidson B
    Hum Pathol; 2012 Apr; 43(4):529-35. PubMed ID: 21864883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of signal transducer and activator of transcription-3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients.
    Shibata N; Kakita A; Takahashi H; Ihara Y; Nobukuni K; Fujimura H; Sakoda S; Sasaki S; Iwata M; Morikawa S; Hirano A; Kobayashi M
    Neurodegener Dis; 2009; 6(3):118-26. PubMed ID: 19372705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?
    van der Harst E; Bruining HA; Jaap Bonjer H; van der Ham F; Dinjens WN; Lamberts SW; de Herder WW; Koper JW; Stijnen T; Proye C; Lecomte-Houcke M; Bosman FT; de Krijger RR
    J Pathol; 2000 Jun; 191(2):175-80. PubMed ID: 10861578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma.
    Lin H; Kolosenko I; Björklund AC; Protsyuk D; Österborg A; Grandér D; Tamm KP
    Exp Cell Res; 2013 Mar; 319(5):600-11. PubMed ID: 23246572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumors.
    Mayer P; Harjung A; Breinig M; Fischer L; Ehemann V; Malz M; Scherübl H; Britsch S; Werner J; Kern MA; Bläker H; Schirmacher P; Bergmann F
    Endocr Relat Cancer; 2012 Jun; 19(3):217-32. PubMed ID: 22194440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.
    Horiguchi A; Oya M; Shimada T; Uchida A; Marumo K; Murai M
    J Urol; 2002 Aug; 168(2):762-5. PubMed ID: 12131365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray.
    Choi JH; Ahn MJ; Park CK; Han HX; Kwon SJ; Lee YY; Kim IS
    APMIS; 2006 Sep; 114(9):619-25. PubMed ID: 16948814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
    Vezzosi D; Bouisson M; Escourrou G; Laurell H; Selves J; Seguin P; Pradayrol L; Caron P; Buscail L
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):63-7. PubMed ID: 16402930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
    Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
    Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.